$8.890
+0.070 (+0.79%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
BBOT-Prognose durch Analyse ähnlicher Charts
Alphio's BBOT stock price prediction model matches the current BridgeBio Oncology Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.85 (-0.44%). The 1-week path is $8.83 (-0.67%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich BridgeBio Oncology Therapeutics Inc-Aktien kaufen?
Helix Acquisition Corp II (BBOT) is not a good buy right now due to its current price of $8.74, which is significantly below analyst price targets ranging from $22 to $29. The stock has a low RSI of 33.785, indicating it is oversold, but the negative catalysts such as a consistent decline in net income and a projected EPS of -0.71 suggest ongoing financial struggles. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.
BBOT schloss am Wednesday bei $8.89, nachdem der Kurs +0.79% gestiegen ist
BridgeBio Oncology Therapeutics Inc (BBOT) last closed at $8.89, gaining +0.79%. These facts feed the 1-day and 1-week BBOT price prediction above.
Prognose-Treiber
Die Prognose-Treiber von BridgeBio Oncology Therapeutics Inc (BBOT) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf BBOT am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für BBOT
Historically the probability of a positive September return for BBOT is 73.91%. October offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.